EMX1
gene geneOn this page
Summary
EMX1 (empty spiracles homeobox 1, HGNC:3340) is a protein-coding gene on chromosome 2p13.2, encoding Homeobox protein EMX1 (Q04741). Transcription factor, which in cooperation with EMX2, acts to generate the boundary between the roof and archipallium in the developing brain.
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in brain development; neuron differentiation; and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including nervous system development; neuroepithelial cell differentiation; and regulation of oligodendrocyte progenitor proliferation. Located in chromosome and nucleolus.
Source: NCBI Gene 2016 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 41 total — 1 pathogenic
- MANE Select transcript:
NM_004097
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:3340 |
| Approved symbol | EMX1 |
| Name | empty spiracles homeobox 1 |
| Location | 2p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000135638 |
| Ensembl biotype | protein_coding |
| OMIM | 600034 |
| Entrez | 2016 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 4 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000258106, ENST00000394111, ENST00000464675, ENST00000473732, ENST00000491023, ENST00000616281, ENST00000967897
RefSeq mRNA: 1 — MANE Select: NM_004097
NM_004097
CCDS: CCDS1921
Canonical transcript exons
ENST00000258106 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000846613 | 72917519 | 72918372 |
| ENSE00002324819 | 72933787 | 72934891 |
| ENSE00003583246 | 72924309 | 72924493 |
Expression profiles
Bgee: expression breadth ubiquitous, 116 present calls, max score 95.86.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.6168 / max 60.1254, expressed in 179 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 20934 | 0.3447 | 140 |
| 20936 | 0.1281 | 63 |
| 20937 | 0.0548 | 31 |
| 20935 | 0.0339 | 14 |
| 20933 | 0.0305 | 10 |
| 20938 | 0.0248 | 9 |
Top tissues by expression
258 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ganglionic eminence | UBERON:0004023 | 95.86 | gold quality |
| cortical plate | UBERON:0005343 | 93.79 | gold quality |
| ventricular zone | UBERON:0003053 | 92.95 | gold quality |
| oocyte | CL:0000023 | 90.78 | gold quality |
| metanephros cortex | UBERON:0010533 | 89.53 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.65 | gold quality |
| right frontal lobe | UBERON:0002810 | 87.38 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 86.68 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 85.37 | gold quality |
| prefrontal cortex | UBERON:0000451 | 85.22 | gold quality |
| cingulate cortex | UBERON:0003027 | 84.17 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 84.00 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 83.89 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.23 | gold quality |
| secondary oocyte | CL:0000655 | 82.56 | gold quality |
| neocortex | UBERON:0001950 | 81.44 | gold quality |
| frontal cortex | UBERON:0001870 | 80.62 | gold quality |
| cerebral cortex | UBERON:0000956 | 78.62 | gold quality |
| embryo | UBERON:0000922 | 77.84 | gold quality |
| kidney | UBERON:0002113 | 77.38 | gold quality |
| amygdala | UBERON:0001876 | 76.02 | gold quality |
| primary visual cortex | UBERON:0002436 | 75.53 | gold quality |
| cortex of kidney | UBERON:0001225 | 74.01 | gold quality |
| Ammon’s horn | UBERON:0001954 | 71.82 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 69.22 | gold quality |
| left testis | UBERON:0004533 | 69.01 | gold quality |
| right testis | UBERON:0004534 | 68.98 | gold quality |
| occipital lobe | UBERON:0002021 | 68.48 | gold quality |
| temporal lobe | UBERON:0001871 | 68.44 | gold quality |
| renal medulla | UBERON:0000362 | 68.02 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-119 | yes | 42.53 |
| E-HCAD-5 | yes | 33.63 |
| E-ANND-3 | no | 1.29 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
2 targets.
| Target | Regulation |
|---|---|
| APC | |
| NRP1 | Activation |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA0612.1 | EMX1 | NK |
| MA0612.2 | EMX1 | NK |
| MA0612.3 | EMX1 | NK |
JASPAR matrix evidence (PMIDs): PMID:23332764, PMID:25215497
Upstream regulators (CollecTRI, top): SIX3
miRNA regulators (miRDB)
34 targeting EMX1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-3151-5P | 99.86 | 63.83 | 1069 |
| HSA-MIR-6892-3P | 99.68 | 66.40 | 1178 |
| HSA-MIR-875-3P | 99.63 | 69.47 | 2548 |
| HSA-MIR-1915-3P | 99.58 | 66.79 | 1988 |
| HSA-MIR-18A-3P | 99.56 | 65.68 | 1092 |
| HSA-MIR-642A-5P | 99.51 | 65.10 | 1152 |
| HSA-MIR-4279 | 99.19 | 66.70 | 2437 |
| HSA-MIR-3190-5P | 98.87 | 64.89 | 1345 |
| HSA-MIR-7851-3P | 98.72 | 64.88 | 980 |
| HSA-MIR-3938 | 98.72 | 66.07 | 834 |
| HSA-MIR-1227-5P | 98.65 | 65.32 | 1549 |
| HSA-MIR-4646-3P | 98.65 | 66.98 | 693 |
| HSA-MIR-4700-5P | 98.63 | 67.43 | 1915 |
| HSA-MIR-9500 | 98.62 | 66.54 | 1845 |
| HSA-MIR-6780A-3P | 98.42 | 67.49 | 1518 |
| HSA-MIR-3155A | 98.16 | 66.09 | 965 |
| HSA-MIR-3155B | 98.16 | 66.09 | 965 |
| HSA-MIR-484 | 98.16 | 66.92 | 1074 |
| HSA-MIR-8089 | 97.74 | 66.21 | 1698 |
| HSA-MIR-4667-5P | 97.61 | 66.67 | 1683 |
| HSA-MIR-6779-3P | 97.51 | 65.82 | 789 |
| HSA-MIR-3116 | 97.07 | 65.78 | 1324 |
| HSA-MIR-6773-5P | 97.04 | 64.30 | 595 |
| HSA-MIR-6724-5P | 96.41 | 63.11 | 507 |
| HSA-MIR-1291 | 96.28 | 65.89 | 1224 |
Literature-anchored findings (GeneRIF, showing 5)
- An intersectional fate-mapping analysis reveals that transgenic Emx1-lineage cells coexpressing Dlx exclusively generate medium spiny neurons but do not contribute to the excitatory neurons in the amygdala. (PMID:20016109)
- Regulation of sarcomagenesis by the empty spiracles homeobox genes EMX1 and EMX2. (PMID:34016958)
- Empty spiracles homeobox genes EMX1 and EMX2 regulate WNT pathway activation in sarcomagenesis. (PMID:34364391)
- EMX1 functions as a tumor inhibitor in spinal cord glioma through transcriptional suppression of WASF2 and inactivation of the Wnt/beta-catenin axis. (PMID:35849030)
- Generation of human excitatory forebrain neurons by cooperative binding of proneural NGN2 and homeobox factor EMX1. (PMID:38446849)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | emx1 | ENSDARG00000039569 |
| mus_musculus | Emx1 | ENSMUSG00000033726 |
| rattus_norvegicus | Emx1 | ENSRNOG00000015493 |
Paralogs (3): VAX2 (ENSG00000116035), VAX1 (ENSG00000148704), EMX2 (ENSG00000170370)
Protein
Protein identifiers
Homeobox protein EMX1 — Q04741 (reviewed: Q04741)
Alternative names: Empty spiracles homolog 1, Empty spiracles-like protein 1
All UniProt accessions (3): A0A087WZF2, Q04741, F8W1B5
UniProt curated annotations — full annotation on UniProt →
Function. Transcription factor, which in cooperation with EMX2, acts to generate the boundary between the roof and archipallium in the developing brain. May function in combinations with OTX1/2 to specify cell fates in the developing central nervous system.
Subunit / interactions. Interacts with WRD11 (via the N-terminal and the central portion of the protein); the interaction associates EMX1 with GLI3.
Subcellular location. Nucleus. Cytoplasm.
Tissue specificity. Cerebral cortex.
Similarity. Belongs to the EMX homeobox family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q04741-1 | 1 | yes |
| Q04741-2 | 2 |
RefSeq proteins (1): NP_004088* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR017970 | Homeobox_CS | Conserved_site |
| IPR020479 | HD_metazoa | Domain |
| IPR050877 | EMX-VAX-Noto_Homeobox_TFs | Family |
Pfam: PF00046
UniProt features (6 total): splice variant 2, chain 1, DNA-binding region 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q04741-F1 | 64.07 | 0.20 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 104 (showing top):
RNGTGGGC_UNKNOWN, GOBP_EMBRYO_DEVELOPMENT_ENDING_IN_BIRTH_OR_EGG_HATCHING, GOBP_EPITHELIUM_DEVELOPMENT, MYOGENIN_Q6, GOBP_NEURON_PROJECTION_EXTENSION, GCANCTGNY_MYOD_Q6, GOBP_GROWTH, GOBP_NEUROGENESIS, GOBP_FOREBRAIN_DEVELOPMENT, GOBP_FOREBRAIN_REGIONALIZATION, GOBP_FOREBRAIN_GENERATION_OF_NEURONS, GOBP_NEURAL_PRECURSOR_CELL_PROLIFERATION, GOBP_CEREBRAL_CORTEX_NEURON_DIFFERENTIATION, GOBP_ANIMAL_ORGAN_MORPHOGENESIS, GOBP_IN_UTERO_EMBRYONIC_DEVELOPMENT
GO Biological Process (18): in utero embryonic development (GO:0001701), regulation of transcription by RNA polymerase II (GO:0006357), central nervous system development (GO:0007417), brain development (GO:0007420), response to xenobiotic stimulus (GO:0009410), post-embryonic development (GO:0009791), cerebral cortex regionalization (GO:0021796), cerebral cortex neuron differentiation (GO:0021895), neuron differentiation (GO:0030182), brain morphogenesis (GO:0048854), homeostasis of number of cells (GO:0048872), radial glial cell differentiation (GO:0060019), neuroepithelial cell differentiation (GO:0060563), regulation of oligodendrocyte progenitor proliferation (GO:0070445), neuron projection extension (GO:1990138), regulation of DNA-templated transcription (GO:0006355), telencephalon development (GO:0021537), cerebral cortex development (GO:0021987)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), protein binding (GO:0005515)
GO Cellular Component (5): chromatin (GO:0000785), nucleus (GO:0005634), chromosome (GO:0005694), nucleolus (GO:0005730), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| anatomical structure development | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| cellular anatomical structure | 2 |
| intracellular membraneless organelle | 2 |
| chordate embryonic development | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| nervous system development | 1 |
| system development | 1 |
| central nervous system development | 1 |
| animal organ development | 1 |
| head development | 1 |
| response to chemical | 1 |
| multicellular organism development | 1 |
| multicellular organismal process | 1 |
| regionalization | 1 |
| telencephalon regionalization | 1 |
| cerebral cortex development | 1 |
| forebrain neuron differentiation | 1 |
| cell differentiation | 1 |
| generation of neurons | 1 |
| brain development | 1 |
| animal organ morphogenesis | 1 |
| multicellular organismal-level homeostasis | 1 |
| glial cell differentiation | 1 |
| columnar/cuboidal epithelial cell differentiation | 1 |
| oligodendrocyte progenitor proliferation | 1 |
| regulation of neural precursor cell proliferation | 1 |
| developmental cell growth | 1 |
| neuron projection morphogenesis | 1 |
| developmental growth involved in morphogenesis | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| forebrain development | 1 |
| pallium development | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
Protein interactions and networks
STRING
1448 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| EMX1 | TBR1 | Q16650 | 804 |
| EMX1 | FOXG1 | P55315 | 785 |
| EMX1 | NEUROD6 | Q96NK8 | 714 |
| EMX1 | SHH | Q15465 | 668 |
| EMX1 | FGF8 | P55075 | 631 |
| EMX1 | BCL11B | Q9C0K0 | 631 |
| EMX1 | NES | P48681 | 626 |
| EMX1 | SATB2 | Q9UPW6 | 624 |
| EMX1 | EOMES | O95936 | 621 |
| EMX1 | FANCF | Q9NPI8 | 619 |
| EMX1 | CUX1 | P39880 | 615 |
| EMX1 | NEUROG2 | Q9H2A3 | 613 |
| EMX1 | PVALB | P20472 | 608 |
| EMX1 | FEZF2 | Q8TBJ5 | 601 |
| EMX1 | CAMK2A | Q9UQM7 | 587 |
IntAct
13 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| WDR11 | EMX1 | psi-mi:“MI:0915”(physical association) | 0.500 |
| GLI3 | EMX1 | psi-mi:“MI:0915”(physical association) | 0.500 |
| GLI3 | EMX1 | psi-mi:“MI:0914”(association) | 0.500 |
| EMX1 | GTF2A1L | psi-mi:“MI:0915”(physical association) | 0.370 |
| EMX1 | PRDM4 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ELK1 | EMX1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| EMX1 | HOXA10 | psi-mi:“MI:0915”(physical association) | 0.370 |
| EMX1 | POLR2D | psi-mi:“MI:0915”(physical association) | 0.370 |
| EMX1 | ALX4 | psi-mi:“MI:0915”(physical association) | 0.370 |
| EMX1 | TP63 | psi-mi:“MI:0915”(physical association) | 0.370 |
| WDR11 | GLI3 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (9): EMX1 (Protein-RNA), HSPH1 (Cross-Linking-MS (XL-MS)), EMX1 (Two-hybrid), HOXA10 (Two-hybrid), POLR2D (Two-hybrid), TP63 (Two-hybrid), GTF2A1L (Two-hybrid), PRDM4 (Two-hybrid), ALX4 (Two-hybrid)
ESM2 similar proteins: A0JPN1, A1YEY5, A1YF16, A1YFI3, A1YG57, A1YG93, A2T733, A2T764, A2T7P4, A6NJ46, A7MB54, O02786, O42230, O43711, O43763, O55144, O57601, O93367, O95096, P09633, P31274, P35548, P42586, P43120, P43345, P43697, P48031, P50223, P52946, P52947, P52951, P53545, P56915, P63156, P63157, Q02591, Q03014, Q03358, Q04741, Q04742
Diamond homologs: A2RU54, A5YC49, A6NHT5, A6NJ46, A8XJD0, D2KQB0, O08686, O35762, O42230, O43711, O43763, O55144, O57601, O70218, O88181, O93366, O93367, O93590, P02830, P15858, P19601, P20269, P22544, P22807, P22809, P28468, P31314, P40764, P42580, P42581, P43345, P43687, P48031, P52950, P53547, P53772, P53775, P56407, P63156, P63157
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| EMX1 | “up-regulates quantity by expression” | NRP1 | “transcriptional regulation” |
Disease & clinical
Clinical variants and AI predictions
ClinVar
41 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 40 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 60181 | GRCh38/hg38 2p13.2(chr2:72861062-72992130)x1 | Pathogenic |
SpliceAI
607 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:72924267:T:TA | acceptor_gain | 1.0000 |
| 2:72924271:T:TA | acceptor_gain | 1.0000 |
| 2:72924274:A:AG | acceptor_gain | 1.0000 |
| 2:72924274:ACCT:A | acceptor_gain | 1.0000 |
| 2:72924275:C:G | acceptor_gain | 1.0000 |
| 2:72924277:T:TA | acceptor_gain | 1.0000 |
| 2:72924279:C:CA | acceptor_gain | 1.0000 |
| 2:72924491:CAGGT:C | donor_loss | 1.0000 |
| 2:72924492:AGG:A | donor_loss | 1.0000 |
| 2:72924493:GGT:G | donor_loss | 1.0000 |
| 2:72924494:GT:G | donor_loss | 1.0000 |
| 2:72924495:T:G | donor_loss | 1.0000 |
| 2:72933779:T:A | acceptor_gain | 1.0000 |
| 2:72918371:GG:G | donor_gain | 0.9900 |
| 2:72918372:GG:G | donor_gain | 0.9900 |
| 2:72924281:T:TA | acceptor_gain | 0.9900 |
| 2:72924283:T:TA | acceptor_gain | 0.9900 |
| 2:72924286:T:A | acceptor_gain | 0.9900 |
| 2:72924289:C:A | acceptor_gain | 0.9900 |
| 2:72924292:C:CA | acceptor_gain | 0.9900 |
| 2:72924295:C:CA | acceptor_gain | 0.9900 |
| 2:72924490:GCAG:G | donor_gain | 0.9900 |
| 2:72933783:CCAG:C | acceptor_loss | 0.9900 |
| 2:72933784:CAGGT:C | acceptor_loss | 0.9900 |
| 2:72933785:A:G | acceptor_loss | 0.9900 |
| 2:72933786:G:GT | acceptor_loss | 0.9900 |
| 2:72924298:C:CA | acceptor_gain | 0.9800 |
| 2:72924494:G:GG | donor_gain | 0.9800 |
| 2:72933780:G:A | acceptor_gain | 0.9800 |
| 2:72933785:A:AG | acceptor_gain | 0.9800 |
AlphaMissense
1862 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000459269 (2:72917019 G>A), RS1000488950 (2:72917279 C>G,T), RS1000605674 (2:72922795 C>T), RS1000792836 (2:72918981 G>A), RS1000805139 (2:72929268 C>G), RS1000948490 (2:72925118 T>C), RS1001002678 (2:72914903 G>T), RS1001038049 (2:72915303 G>A,C), RS1001240730 (2:72934613 C>A,T), RS1001521130 (2:72916056 T>C), RS1001594889 (2:72930365 G>A), RS1001599260 (2:72921262 G>A,T), RS1001672492 (2:72918555 G>T), RS1001744991 (2:72920965 T>C), RS1001777544 (2:72924231 C>T)
Disease associations
OMIM: gene MIM:600034 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004946_91 | Schizophrenia | 2.000000e-10 |
| GCST007201_21 | Schizophrenia | 1.000000e-08 |
| GCST010725_60 | Malaria | 7.000000e-06 |
| GCST010725_79 | Malaria | 5.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | increases expression, affects response to substance | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| pyrachlostrobin | decreases expression | 1 |
| bisphenol S | decreases methylation | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| picoxystrobin | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Copper | decreases expression, affects cotreatment | 1 |
| Lipopolysaccharides | affects response to substance, increases expression | 1 |
| Rotenone | decreases expression | 1 |
| Smoke | increases expression | 1 |
| Testosterone | increases expression | 1 |
| Triclosan | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Asbestos, Crocidolite | decreases methylation | 1 |
| Asbestos, Amosite | decreases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.